| NMIBC | Non-muscle invasive bladder cancer |
| EAU | European Association of Urology |
| TURBT | Trans-urethral resection of bladder tumor |
| UB | Urinary microbiome |
| TMB | Tumor mutational burden |
| BPH | Benign prostatic hyperplasia |
| LUTS | Lower urinary tract symptoms |
| STD | Sexually transmitted disorders |
| IPSS | International Prostate Symptom Score |
| NGS | Next-generation sequencing |
| BC | Bladder cancer |
| HBD | Human beta-defensins |
| UTI | Urinary tract infections |
| RC | Radical cystectomy |
| AUC | Area under the curve |
| FM | First-morning urine |
| HPV | Human Papillomavirus |
| IVT | Intravesical therapy |
| iAs | Inorganic arsenic |